vs

Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and First Watch Restaurant Group, Inc. (FWRG). Click either name above to swap in a different company.

First Watch Restaurant Group, Inc. is the larger business by last-quarter revenue ($316.4M vs $196.0M, roughly 1.6× Axsome Therapeutics, Inc.). On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 20.2%). First Watch Restaurant Group, Inc. produced more free cash flow last quarter ($-18.3M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 14.2%).

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.

Ruby Tuesday Inc. is an American multinational foodservice retailer that owns, operates, and franchises Ruby Tuesday restaurants. The concept was started in 1972 by Samuel E. (Sandy) Beall III.

AXSM vs FWRG — Head-to-Head

Bigger by revenue
FWRG
FWRG
1.6× larger
FWRG
$316.4M
$196.0M
AXSM
Growing faster (revenue YoY)
AXSM
AXSM
+44.9% gap
AXSM
65.0%
20.2%
FWRG
More free cash flow
FWRG
FWRG
$386.0K more FCF
FWRG
$-18.3M
$-18.7M
AXSM
Faster 2-yr revenue CAGR
AXSM
AXSM
Annualised
AXSM
61.7%
14.2%
FWRG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
AXSM
AXSM
FWRG
FWRG
Revenue
$196.0M
$316.4M
Net Profit
$-28.6M
Gross Margin
Operating Margin
-13.8%
2.9%
Net Margin
-14.6%
Revenue YoY
65.0%
20.2%
Net Profit YoY
61.9%
EPS (diluted)
$-0.55
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXSM
AXSM
FWRG
FWRG
Q4 25
$196.0M
$316.4M
Q3 25
$171.0M
$316.0M
Q2 25
$150.0M
$307.9M
Q1 25
$121.5M
$282.2M
Q4 24
$118.8M
$263.3M
Q3 24
$104.8M
$251.6M
Q2 24
$87.2M
$258.6M
Q1 24
$75.0M
$242.4M
Net Profit
AXSM
AXSM
FWRG
FWRG
Q4 25
$-28.6M
Q3 25
$-47.2M
$3.0M
Q2 25
$-48.0M
$2.1M
Q1 25
$-59.4M
$-829.0K
Q4 24
$-74.9M
Q3 24
$-64.6M
$2.1M
Q2 24
$-79.3M
$8.9M
Q1 24
$-68.4M
$7.2M
Operating Margin
AXSM
AXSM
FWRG
FWRG
Q4 25
-13.8%
2.9%
Q3 25
-27.0%
3.2%
Q2 25
-24.5%
2.4%
Q1 25
-46.9%
0.4%
Q4 24
-61.1%
1.5%
Q3 24
-59.8%
2.5%
Q2 24
-89.5%
6.4%
Q1 24
-89.7%
5.1%
Net Margin
AXSM
AXSM
FWRG
FWRG
Q4 25
-14.6%
Q3 25
-27.6%
0.9%
Q2 25
-32.0%
0.7%
Q1 25
-48.9%
-0.3%
Q4 24
-63.1%
Q3 24
-61.7%
0.8%
Q2 24
-91.0%
3.4%
Q1 24
-91.1%
3.0%
EPS (diluted)
AXSM
AXSM
FWRG
FWRG
Q4 25
$-0.55
$0.24
Q3 25
$-0.94
$0.05
Q2 25
$-0.97
$0.03
Q1 25
$-1.22
$-0.01
Q4 24
$-1.54
$0.01
Q3 24
$-1.34
$0.03
Q2 24
$-1.67
$0.14
Q1 24
$-1.44
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXSM
AXSM
FWRG
FWRG
Cash + ST InvestmentsLiquidity on hand
$322.9M
$21.2M
Total DebtLower is stronger
$269.1M
Stockholders' EquityBook value
$88.3M
$626.3M
Total Assets
$689.8M
$1.7B
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXSM
AXSM
FWRG
FWRG
Q4 25
$322.9M
$21.2M
Q3 25
$325.3M
$20.7M
Q2 25
$303.0M
$19.2M
Q1 25
$300.9M
$18.6M
Q4 24
$315.4M
$33.3M
Q3 24
$327.3M
$51.1M
Q2 24
$315.7M
$45.1M
Q1 24
$331.4M
$43.2M
Total Debt
AXSM
AXSM
FWRG
FWRG
Q4 25
$269.1M
Q3 25
$251.0M
Q2 25
$250.0M
Q1 25
$191.5M
Q4 24
$189.0M
Q3 24
$189.7M
Q2 24
$192.1M
Q1 24
$122.7M
Stockholders' Equity
AXSM
AXSM
FWRG
FWRG
Q4 25
$88.3M
$626.3M
Q3 25
$73.7M
$607.3M
Q2 25
$73.1M
$601.3M
Q1 25
$53.2M
$596.3M
Q4 24
$57.0M
$595.4M
Q3 24
$92.9M
$589.1M
Q2 24
$102.9M
$585.8M
Q1 24
$144.0M
$574.4M
Total Assets
AXSM
AXSM
FWRG
FWRG
Q4 25
$689.8M
$1.7B
Q3 25
$669.3M
$1.7B
Q2 25
$639.8M
$1.7B
Q1 25
$596.7M
$1.5B
Q4 24
$568.5M
$1.5B
Q3 24
$561.5M
$1.5B
Q2 24
$548.2M
$1.4B
Q1 24
$545.7M
$1.3B
Debt / Equity
AXSM
AXSM
FWRG
FWRG
Q4 25
0.43×
Q3 25
0.41×
Q2 25
0.42×
Q1 25
0.32×
Q4 24
0.32×
Q3 24
0.32×
Q2 24
0.33×
Q1 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXSM
AXSM
FWRG
FWRG
Operating Cash FlowLast quarter
$-18.7M
$18.5M
Free Cash FlowOCF − Capex
$-18.7M
$-18.3M
FCF MarginFCF / Revenue
-9.6%
-5.8%
Capex IntensityCapex / Revenue
0.0%
11.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-93.9M
$-31.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXSM
AXSM
FWRG
FWRG
Q4 25
$-18.7M
$18.5M
Q3 25
$1.0M
$47.9M
Q2 25
$-32.4M
$39.4M
Q1 25
$-43.4M
$20.1M
Q4 24
$-26.2M
$22.9M
Q3 24
$-18.6M
$35.9M
Q2 24
$-30.1M
$31.9M
Q1 24
$-53.5M
$25.0M
Free Cash Flow
AXSM
AXSM
FWRG
FWRG
Q4 25
$-18.7M
$-18.3M
Q3 25
$988.0K
$5.5M
Q2 25
$-32.4M
$-1.7M
Q1 25
$-43.7M
$-16.4M
Q4 24
$-26.2M
$-17.7M
Q3 24
$-18.7M
$6.8M
Q2 24
$-30.2M
$2.3M
Q1 24
$-53.6M
$-3.6M
FCF Margin
AXSM
AXSM
FWRG
FWRG
Q4 25
-9.6%
-5.8%
Q3 25
0.6%
1.7%
Q2 25
-21.6%
-0.5%
Q1 25
-36.0%
-5.8%
Q4 24
-22.1%
-6.7%
Q3 24
-17.9%
2.7%
Q2 24
-34.6%
0.9%
Q1 24
-71.4%
-1.5%
Capex Intensity
AXSM
AXSM
FWRG
FWRG
Q4 25
0.0%
11.6%
Q3 25
0.0%
13.4%
Q2 25
0.0%
13.4%
Q1 25
0.3%
13.0%
Q4 24
0.0%
15.4%
Q3 24
0.1%
11.6%
Q2 24
0.1%
11.5%
Q1 24
0.1%
11.8%
Cash Conversion
AXSM
AXSM
FWRG
FWRG
Q4 25
Q3 25
16.01×
Q2 25
18.72×
Q1 25
Q4 24
Q3 24
16.98×
Q2 24
3.59×
Q1 24
3.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AXSM
AXSM

Segment breakdown not available.

FWRG
FWRG

In Restaurant Dining Sales$254.1M80%
Third Party Delivery Sales$38.6M12%
Take Out Sales$21.3M7%
Royalty And System Fund Contributions$2.3M1%

Related Comparisons